CHOP-like regimen in combination with rituximab and peginterferon alpha-2b in newly-diagnosed diffuse large B-cell Non-Hodgkin’s lymphoma: Experience in a Chinese center-Reference-Cited by-同舟云学术

CHOP-like regimen in combination with rituximab and peginterferon alpha-2b in newly-diagnosed diffuse large B-cell Non-Hodgkin’s lymphoma: Experience in a Chinese center

Published:2010-04 Issue:2 Volume:7 Page:103-109
ISSN:1674-5361
Container-title:Clinical Oncology and Cancer Research
language:en
Short-container-title:Clin. Oncol. Cancer Res.

Author:

Lü Shu-qing,Yang Jian-min,Song Xian-min,Chen Li,Zhang Wei-ping,Xu Xiao-qian,Ni Xiong,Huang Chong-mei,He Yi,Wang Jian-min

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11805-010-0503-2.pdf

Reference24 articles.

1. Zhang YN, Zhou XG, Zhang SH, et al. Clinicopathologic study of 369 B-cell non-Hodgkin lymphoma cases, with reference to the 2001 World Health Organization classification of lymphoid neoplasms. Zhonghua Binglixue Zazhi 2005; 34:193–197 (Chinese).

2. Yin HF, Li T, Li JX. Retrospective analysis of 304 cases of malignant lymphomas in pathology: study and practice of the WHO classification of lymphoid neoplasms. Zhonghua Yixue Zazhi. 2003; 83: 1556–1560 (Chinese).

3. Coiffier B, Lepage E, Briere J, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large B-cell lymphoma. N Engl J Med 2002; 346: 235–242.

4. Sehn LH, Donaldson J, Chhanabhai M, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol 2005; 23: 5027–5033.

5. Li JM, Wang L, Shen Y, et al. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Chinese patients. Ann Hematol 2007; 86: 639–645.